Recombinant Human NUP35 Protein，His

NUP35, also known as nucleoporin 35, is a critical component of the nuclear pore complex (NPC), which serves as the gateway for nucleocytoplasmic transport of molecules. Research into NUP35 has garnered attention due to its essential role in maintaining nuclear envelope integrity and regulating gene expression by controlling the exchange of proteins and RNA between the nucleus and cytoplasm. This protein is part of the larger family of nucleoporins, which collectively contribute to the structural framework and functional dynamics of the NPC. Abnormalities in NUP35 expression or function have been implicated in various diseases, including cancer and genetic disorders, highlighting its potential as a biomarker and therapeutic target. Recent advances in recombinant protein technology have facilitated the production of NUP35, enabling detailed structural and biochemical studies. These studies aim to elucidate NUP35's role within the NPC and its interactions with other nucleoporins and transport factors. Understanding the exact mechanisms by which NUP35 operates can provide valuable insights into the fundamental processes of cellular communication and transport, as well as the pathological consequences of its dysfunction. Thus, the research on recombinant NUP35 not only enhances our grasp of nuclear transport mechanisms but also opens avenues for developing innovative therapeutic strategies to address diseases associated with nucleocytoplasmic transport dysregulation.